Screener
Hemab Therapeutics Holdings, Inc. COAG Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Hemab Therapeutics Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344533
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other (expense) income, net | (832) | 3,517 | (1,114) | 4,108 |
| Total other income, net | 2,026 | 3,852 | 2,963 | 4,916 |
| Loss before income tax expense | (24,053) | (12,205) | (46,728) | (27,701) |
| Income tax (expense) benefit | (97) | (4) | (109) | 186 |
| Net loss | $(24,150) | $(12,209) | $(46,837) | $(27,515) |
| Net loss per share, basic and diluted | $(0.80) | $(12.91) | $(3.00) | $(29.09) |
| Weighted average shares outstanding, basic and diluted | 30,111,338 | 946,000 | 15,609,236 | 946,000 |
| Other comprehensive loss |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Hemab Therapeutics Holdings, Inc.'s income tax?
- Hemab Therapeutics Holdings, Inc. (COAG) reported income tax of $97K in Q2 2026.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Hemab Therapeutics Holdings, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude